FERRARI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.419
AS - Asia 5.128
EU - Europa 3.461
SA - Sud America 817
AF - Africa 129
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.960
Nazione #
US - Stati Uniti d'America 6.178
VN - Vietnam 1.556
SG - Singapore 1.338
IT - Italia 1.212
CN - Cina 1.049
BR - Brasile 610
HK - Hong Kong 530
DE - Germania 445
RU - Federazione Russa 406
SE - Svezia 205
IE - Irlanda 200
GB - Regno Unito 198
CA - Canada 173
FR - Francia 169
IN - India 130
FI - Finlandia 96
UA - Ucraina 96
BD - Bangladesh 88
ID - Indonesia 78
NL - Olanda 78
AR - Argentina 76
KR - Corea 70
AT - Austria 68
DK - Danimarca 64
ES - Italia 60
ZA - Sudafrica 53
MX - Messico 47
TR - Turchia 47
PL - Polonia 43
IQ - Iraq 40
CO - Colombia 37
JP - Giappone 28
PK - Pakistan 27
VE - Venezuela 27
PH - Filippine 25
SA - Arabia Saudita 24
CH - Svizzera 23
EC - Ecuador 22
BE - Belgio 18
CL - Cile 17
CZ - Repubblica Ceca 17
LT - Lituania 16
MA - Marocco 16
UZ - Uzbekistan 16
TN - Tunisia 13
JO - Giordania 12
PY - Paraguay 11
ET - Etiopia 10
IL - Israele 9
IR - Iran 9
KE - Kenya 9
PE - Perù 9
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
AL - Albania 6
GR - Grecia 6
MY - Malesia 6
PT - Portogallo 6
RS - Serbia 6
BO - Bolivia 5
NP - Nepal 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
JM - Giamaica 4
NO - Norvegia 4
PA - Panama 4
TT - Trinidad e Tobago 4
CY - Cipro 3
DO - Repubblica Dominicana 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BY - Bielorussia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
SI - Slovenia 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
Totale 15.949
Città #
Ann Arbor 961
Singapore 771
Ashburn 644
Hong Kong 519
Ho Chi Minh City 448
Hanoi 429
Fairfield 408
Milan 400
San Jose 391
Frankfurt am Main 287
Woodbridge 273
Wilmington 248
Dallas 234
Houston 209
Chandler 199
Dublin 192
New York 178
Seattle 168
Cambridge 144
Beijing 142
Hefei 135
Los Angeles 127
Santa Clara 120
Chicago 105
Toronto 98
Dearborn 93
Rome 83
Jacksonville 82
Council Bluffs 72
Shanghai 70
The Dalles 70
Princeton 69
Dong Ket 64
Seoul 62
Lauterbourg 61
São Paulo 61
Jakarta 55
Buffalo 54
Vienna 52
Haiphong 50
Helsinki 50
Nanjing 49
Moscow 43
Da Nang 41
Guangzhou 36
Warsaw 35
Lawrence 34
Munich 34
Quận Bình Thạnh 33
Johannesburg 31
Montreal 30
London 29
Biên Hòa 27
Hyderabad 26
San Diego 26
Altamura 25
Orem 25
Denver 24
Hải Dương 24
Atlanta 23
Poplar 23
Rio de Janeiro 22
Nuremberg 21
Zurich 21
Turin 20
Turku 19
Amsterdam 17
Can Tho 17
Ha Long 17
Nanchang 17
Shenyang 17
Thái Nguyên 17
Baghdad 16
Brussels 16
Mexico City 16
Tokyo 16
Boardman 15
Bologna 15
Changsha 15
Dhaka 15
Newark 15
San Francisco 15
Andover 14
Brooklyn 14
Kent 14
Phoenix 14
Piscataway 14
Stockholm 14
Tashkent 14
Vũng Tàu 14
Bari 13
Brno 13
Chennai 13
Genoa 13
Lachine 13
Lang Son 13
Lappeenranta 13
Messina 13
Ninh Bình 13
Zhengzhou 13
Totale 10.097
Nome #
Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 1.142
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 789
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats 386
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 377
Human neural stem cell transplantation in ALS: Initial results from a phase I trial 338
Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family 321
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 310
Morphological and metabolic changes in microglia exposed to cadmium: Cues on neurotoxic mechanisms 309
A link between genetic disorders and cellular impairment, using human induced pluripotent stem cells to reveal the functional consequences of copy number variations in the central nervous system—a close look at chromosome 15 306
Immortalization of human neural stem cells with the c-myc mutant T58A 300
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis 297
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome 296
Mild hypoxia enhances proliferation and multipotency of human neural stem cells 287
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies 284
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease 268
Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy 267
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 266
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 262
Preliminary data of intracerebroventricular transplantation of human-Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 258
Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage 256
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine 255
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850) 253
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 252
Neural stem cells and human induced pluripotent stem cells to model rare CNS diseases 251
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. 250
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment 250
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA) 249
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein 244
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation 243
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 243
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 242
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein 240
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment 239
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease 237
Isolation of neural stem cells from neural tissues using the neurosphere technique 236
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression 236
Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model 236
Unique expression and localization of aquaporin-4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny 229
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene 223
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization 222
Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smithâ Magenis syndrome 218
Advances in stem cell therapy for amyotrophic lateral sclerosis 218
Exploring the metabolic signature of ALS patients-derived cells 212
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 208
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 206
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 203
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene 202
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 200
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 199
Exploring the metabolic signature of Amyotrophic Lateral Sclerosis patients-derived cells 199
Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies 193
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft 190
Inorganic mercury changes the fate of murine CNS stem cells 185
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation 177
The stem cells as a potential treatment for neurodegeneration 166
Culturing and Expansion of “Clinical Grade” Neural Stem Cells from the Fetal Human Central Nervous System 165
Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS 159
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 159
INTERROGATING ALS SIGNATURE IN HUMAN INDUCED NEURAL STEM CELLS 152
Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate 151
INTERROGATING ALS SIGNATURE IN EARLY NEURAL PROGENITOR CELLS: A DIFFERENT PERSPECTIVE 137
Brain Organoids to Evaluate Cellular Therapies 135
Uncovering primary cilium defects in Joubert Syndrome using iPSCs derived-Neural Stem Cells 114
Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia 83
Totale 16.380
Categoria #
all - tutte 46.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 58 174
2021/2022607 63 82 75 27 20 40 48 72 30 27 58 65
2022/20231.057 89 269 139 111 93 147 10 51 58 23 39 28
2023/2024909 26 29 56 73 103 188 148 42 68 35 32 109
2024/20253.666 126 195 242 138 183 123 156 110 302 430 251 1.410
2025/20266.514 669 680 547 817 763 357 852 318 588 678 245 0
Totale 16.380